EPO and anemia: If antibodies against p17 did drive the generation of anti-EPO autoantibodies and anemia in HIV patients, it is difficult to reconcile the reported decrease in EPO autoantibodies following one year of ART [12] because highly elevated levels of anti-p17 and other HIV antibodies persist and remain unchanged years after HAART [5,6].